A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Clinical trial NCT06247787 · RECRUITING

Trial details

NCT number: NCT06247787
Sponsor: Children's Oncology Group
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Myelodysplastic Syndrome Recurrent Juvenile Myelomonocytic Leukemia Refractory Childhood Acute Myeloid Leukemia Refractory Childhood Myelodysplastic Syndrome Refractory Juvenile Myelomonocytic Leukemia

Start date: 2025-02-04
Primary completion: 2028-03-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.